Toby Proctor is Head of Manufacturing Science & Technology at Achilles Therapeutics Ltd, an AI-powered precision cell therapy company developing adoptive T cell therapies for the treatment of solid tumours. He obtained his EngD in Biochemical Engineering from University College London, UK, developing novel, closed systems for the production of tissue engineered AT(I)MPs. Toby acts as the technical lead for internal, device development activities at Achilles Therapeutics and has experience transitioning projects from conceptualisation through to production. As Head of MSAT at Achilles Therapeutics he oversees a multidisciplinary team of engineers and scientists focused on bioprocess innovation, alongside the integration of new technologies and development of pipeline products. Toby also sits on the Phacilitate Automation Special Interest Group